Genetic Testing in Cancer

19-06-2026

Inherited risk and preventive strategies

The role of genetic testing is significant in terms of identifying inherited mutations through germline testing. The process involves analyzing DNA from blood or saliva to find genetic markers that increase a person’s lifetime risk for specific cancers. If the result is positive, it promotes proactive prevention through life-saving interventions, like colonoscopies or mammograms.

Once a specific mutation is found in one person, the blood relatives can be tested for the same specific marker, which in turn helps them to understand their own risks. Therefore, early detection and risk reduction strategies can be ensured through genetic testing. You can seek early detection at a reputed cancer hospital near you, such as Hope and Heal Cancer Hospital.

Precision diagnostics and treatment guidance

In the context of active cancer, genetic testing helps in making informed decisions and selecting highly personalized therapies. Cancer specialists can determine if a person is eligible for specific clinical trials or cutting-edge technologies based on the analysis of genetic makeup. On the other hand, molecular profiling is crucial for personalized drug selection, which is crucial for cancers like lung or breast cancers.

The key is to identify specific mutations, such as ALK and EGFR, which are made possible through genetic testing. Overall, a targeted approach reduces the side effects, along with increasing the effectiveness of the treatment, which is achieved through identifying mutations by genetic testing.